Publicaciones en colaboración con investigadores/as de Stanford University (43)

2024

  1. A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results

    Haemophilia

  2. A road map for the treatment of pediatric diffuse midline glioma

    Cancer Cell

  3. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  4. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  5. Towards a more inductive world for drug repurposing approaches

    Zenodo

  6. Towards a more inductive world for drug repurposing approaches

    Zenodo

2023

  1. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  2. Identifying key multifunctional components shared by critical cancer and normal liver pathways via SparseGMM

    Cell Reports Methods, Vol. 3, Núm. 1

2021

  1. Elevated NSD3 histone methylation activity drives squamous cell lung cancer

    Nature, Vol. 590, Núm. 7846, pp. 504-508

  2. International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials

    Leukemia, Vol. 35, Núm. 1, pp. 18-30

  3. Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer

    JAMA Network Open, Vol. 4, Núm. 12, pp. E2138550

  4. Small molecule-based enzyme inhibitors in the treatment of primary hyperoxalurias

    Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-31

2020

  1. Comparison of single and module-based methods for modeling gene regulatory networks

    Bioinformatics, Vol. 36, Núm. 2, pp. 558-567

2019

  1. Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma

    Nature Medicine, Vol. 25, Núm. 11, pp. 1783-1795

  2. Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation

    Neurotherapeutics, Vol. 16, Núm. 3, pp. 808-827

  3. Benchmark of long non-coding RNA quantification for RNA sequencing of cancer samples

    GigaScience, Vol. 8, Núm. 12

  4. Denoising of Aligned Genomic Data

    Scientific Reports, Vol. 9, Núm. 1

  5. Genomic Data Compression

    Annual Review of Biomedical Data Science, Vol. 2, pp. 19-37

  6. SPRING: A next-generation compressor for FASTQ data

    Bioinformatics, Vol. 35, Núm. 15, pp. 2674-2676

2017

  1. An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer

    Nature Communications, Vol. 8